Search Results - "Tapprich, C."

Cyclosporine a and mycophenolate mofetil vs cyclosporine a and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings by NEUMANN, F, GRAEF, T, TAPPRICH, C, VAUPEL, M, STEIDL, U, GERMING, U, FENK, R, HINKE, A, HAAS, R, KOBBE, G

“…The combination of Cyclosporin A (CSA) and Methotrexate (MTX) is considered to be the standard regimen for the prevention of graft-versus-host disease (GVHD)…”
Get full text

Prevalence and Treatment of Chronic Lymphocytic Leukaemia (Cll) In Germany: An Analysis of Sickness Funds by Tomeczkowski, J, Leisten, M.K, Metin, H, Khuen, C, Fleischmann, J, Tapprich, C

Get full text

PCN27 Analysis of Prevalence and Treatment of Multiple Myeloma in German Statutory Sick Funds Claim Data by Tomeczkowski, J, Wirth, D, Tapprich, C, Knauf, W

Get full text

Analyses Adjusting for Selective Crossover Show Improved Overall Survival with Decitabine Compared with Treatment Choice in DACO-016 Phase III Trial by Tomeczkowski, J, Güntert, A, Thilakarathne, P, Diels, J, Xiu, L, Tapprich, C

Get full text

PCN2 Data Analyses on Prevalence and Treatment of Acute Myeloid Leukaemia in Germany by Tomeczkowski, J, Theidel, U, Mittendorf, T, Fleischmann, J, Tapprich, C

Get full text

Early recurrence of rheumatoid arthritis after nonmyeloablative allogeneic blood stem cell transplantation in a patient with multiple myeloma by TAPPRICH, C, FENK, R, SCHNEIDER, P, BERNHARDT, A, HAAS, R, KOBBE, G

“…Allogeneic blood stem cell transplantation with reduced conditioning has been proposed as a new, potentially curative treatment option for patients with…”
Get full text

PCN479 PATIENT-REPORTED SYMPTOM BURDEN OF CHRONIC GRAFT VERSUS HOST DISEASE: A SYSTEMATIC LITERATURE REVIEW by Csanádi, M., Farkas, S., Gros Otero, B., Bacon, T., Tapprich, C., Trudeau, J., Agh, T.

Get full text

Review Of Real-World Evidence To Assess The Burden Of Illness Of Mantle Cell Lymphoma by Monga, N, Garside, J, Quigley, JM, O'Rourke, JM, O'Donovan, P, Padhiar, A, Parisi, L, Tapprich, C

“…OBJECTIVES: Mantle cell lymphoma (MCL), a rare and aggressive disease, accounts for approximately 5% of all B-cell non-Hodgkin's lymphomas. This review aimed…”
Get full text

PCN318 - Review Of Real-World Evidence To Assess The Burden Of Illness Of Mantle Cell Lymphoma by Monga, N, Garside, J, Quigley, JM, O'Rourke, JM, O'Donovan, P, Padhiar, A, Parisi, L, Tapprich, C

Get full text

PSY66 - Identifying Evidence on The Cost-Effectiveness of Treatments And Costs/Resource Use And Quality of Life of Patients with Follicular Lymphoma And Marginal Zone Lymphoma: Systematic Reviews by Monga, N, Garside, J, Gurung, B, Quigley, JM, O'Donovan, P, Padhiar, A, Parisi, L, Tapprich, C, Nastoupil, L

Get full text

Identifying Evidence on The Cost-Effectiveness of Treatments And Costs/Resource Use And Quality of Life of Patients with Follicular Lymphoma And Marginal Zone Lymphoma: Systematic Reviews by Monga, N, Garside, J, Gurung, B, Quigley, JM, O'Donovan, P, Padhiar, A, Parisi, L, Tapprich, C, Nastoupil, L

“…OBJECTIVES: Systematic reviews were conducted to identify evidence on the cost-effectiveness of treatments, costs/resource use, and…”
Get full text

REVIEW OF BURDEN OF ILLNESS DATA FOR FOLLICULAR LYMPHOMA AND MARGINAL ZONE LYMPHOMA by Monga, N, Garside, J, Quigley, JM, O’Donovan, P, Ward, KE, Padhiar, A, Parisi, L, Tapprich, C

“…OBJECTIVES: Indolent Non-Hodgkin Lymphomas (NHL) including follicular lymphoma (FL) and marginal zone lymphoma (MZL) compromise approximately 12% of all NHLs…”
Get full text

PCN282 - Chemotherapy Exposure and outcomes Among Patients Diagnosed with Chronic Lymphoid Leukemia by Kuiper, JG, Musingarimi, P, Tapprich, C, Penning-van Beest, FJ, Gaudig, M

Get full text

PSY15 - Prevalence and Treatment of Chronic Lymphocytic Leukaemia (Cll) In Germany: An Analysis of Sickness Funds by Tomeczkowski, J., Leisten, M.K., Metin, H., Khuen, C., Fleischmann, J., Tapprich, C.

Get full text

Chemotherapy Exposure and outcomes Among Patients Diagnosed with Chronic Lymphoid Leukemia by Kuiper, JG, Musingarimi, P, Tapprich, C, Penning-van Beest, FJ, Gaudig, M

Get full text

PSY6 - Analyses Adjusting for Selective Crossover Show Improved Overall Survival with Decitabine Compared with Treatment Choice in DACO-016 Phase III Trial by Tomeczkowski, J., Güntert, A., Thilakarathne, P., Diels, J., Xiu, L., Tapprich, C.

Get full text

Optimized PCR fragments for heteroduplex analysis of the whole human mitochondrial genome with denaturing HPLC by Wulfert, Michael, Tapprich, Christoph, Gattermann, Norbert

“…Denaturing high pressure liquid chromatography (dHPLC) is an efficient method for discovery of unknown mutations by heteroduplex analysis of PCR fragments. For…”
Get full text